Sign in
Laboratory, Clinical, and Survival Outcomes Associated With Peptide Receptor Radionuclide Therapy in Patients With Gastroenteropancreatic Neuroendocrine Tumors
Journal article   Peer reviewed

Laboratory, Clinical, and Survival Outcomes Associated With Peptide Receptor Radionuclide Therapy in Patients With Gastroenteropancreatic Neuroendocrine Tumors

Sarit T. Kipnis, Matthew Hung, Shria Kumar, Jason M. Heckert, Hwan Lee, Bonita Bennett, Michael C. Soulen, Daniel A. Pryma, David A. Mankoff, David C. Metz, …
JAMA network open, Vol.4(3), pp.e212274-e212274
2021-03-23
PMID: 33755166

Abstract

Oncology Online Only Original Investigation
This cohort study examines laboratory, clinical, and survival outcomes among patients with gastroenteropancreatic neuroendocrine tumors (NETs) treated with peptide receptor radionuclide therapy.

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics
1 Clinical & Life Sciences
1.195 Neuroendocrine & Intestinal Disorders
1.195.565 Neuroendocrine Tumors
Web Of Science research areas
Oncology
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details